RemSleep Holdings (RMSL) Enterprise Value (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.63% |
| Sep 30, 2025 | 17.32% |
| Jun 30, 2025 | 19.67% |
| Mar 31, 2025 | -9.61% |
| Dec 31, 2024 | 11.66% |
| Sep 30, 2024 | 23.47% |
| Jun 30, 2024 | 4.37% |
| Mar 31, 2024 | -1.60% |
| Dec 31, 2023 | 20.49% |
| Sep 30, 2023 | 16.44% |
| Jun 30, 2023 | 26.11% |
| Mar 31, 2023 | 20.48% |
| Dec 31, 2022 | 14.76% |
| Sep 30, 2022 | 9.71% |
| Jun 30, 2022 | 40.38% |
| Mar 31, 2022 | -18.65% |
| Dec 31, 2021 | -43.13% |
| Sep 30, 2021 | -573.69% |
| Jun 30, 2021 | -120.86% |
| Mar 31, 2021 | -39.09% |
| Dec 31, 2020 | -17.96% |
| Sep 30, 2020 | -102.84% |
| Jun 30, 2020 | 81.18% |
| Mar 31, 2020 | -112.14% |
| Dec 31, 2019 | -17.59% |
| Sep 30, 2019 | 44.06% |
| Jun 30, 2019 | -309.82% |
| Mar 31, 2019 | -166.54% |
| Dec 31, 2018 | 59.37% |
| Sep 30, 2018 | -7,305.97% |
| Jun 30, 2018 | 98.94% |
| Mar 31, 2018 | -2,494.89% |
| Dec 31, 2017 | -3,561.82% |
| Sep 30, 2013 | 100.63% |
| Jun 30, 2013 | 77.43% |
| Mar 31, 2013 | -46.44% |
| Dec 31, 2012 | 97.45% |
| Sep 30, 2012 | -396.82% |
| Jun 30, 2012 | 0.00% |
| Mar 31, 2012 | 40.15% |
| Dec 31, 2011 | 88.86% |
| Sep 30, 2011 | -426.80% |